Works by Omri, Nativ


Results: 14
    1
    2
    3
    4
    5
    6

    Reply to Veerman et al. Comment on "Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12 , 410".

    Published in:
    Journal of Personalized Medicine, 2022, v. 12, n. 6, p. 861, doi. 10.3390/jpm12060861
    By:
    • Rosenzweig, Barak;
    • Haramaty, Rennen;
    • Davidson, Tima;
    • Lazarovich, Alon;
    • Shvero, Asaf;
    • Haifler, Miki;
    • Gal, Jonathan;
    • Golan, Shay;
    • Shpitzer, Sagi;
    • Hoffman, Azik;
    • Nativ, Omri;
    • Freifeld, Yuval;
    • Zreik, Rani;
    • Dotan, Zohar A.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12

    Combined neoadjuvant and adjuvant therapy versus adjuvant therapy in high-risk upper tract urothelial carcinoma: a propensity matched multicenter analysis (ROBUUST 2.0 International Collaborative Group).

    Published in:
    World Journal of Urology, 2025, v. 43, n. 1, p. 1, doi. 10.1007/s00345-025-05605-5
    By:
    • Eraky, Ahmed;
    • Ben-David, Reuben;
    • Bignante, Gabriele;
    • Wu, Zhenjie;
    • Wang, Linhui;
    • Lee, Randall;
    • Correa, Andres F.;
    • Eun, Daniel D.;
    • Antonelli, Alessandro;
    • Veccia, Alessandro;
    • Ditonno, Francesco;
    • Abdollah, Firas;
    • Stephens, Alex;
    • Tinsley, Shane;
    • Sidhom, Daniel;
    • Sundaram, Chandru P.;
    • Moon, Sol C.;
    • Rais-Bahrami, Soroush;
    • Gonzalgo, Mark L.;
    • Nativ, Omri Falik
    Publication type:
    Article
    13
    14